US stem cell clinics, patient safety, and the FDA

Leigh Turner

doi:10.1016/j.molmed.2015.02.008

US stem cell clinics, patient safety, and the FDA

Leigh Turner

Center for Bioethics

Research output: Contribution to journal › Comment/debate › peer-review

52 Scopus citations

Abstract

Scholarship on patients accessing unproven stem cell interventions is dominated by research addressing 'stem cell tourism' to such countries as China, India, Mexico, and the Ukraine. However, clinics marketing 'adipose-derived mesenchymal stem cell treatments' are proliferating across the USA. These businesses typically claim to operate in compliance with federal regulations, but careful review of their commercial practices suggests that such clinics are marketing unapproved and noncompliant biological drugs.

Original language	English (US)
Pages (from-to)	271-273
Number of pages	3
Journal	Trends in Molecular Medicine
Volume	21
Issue number	5
DOIs	https://doi.org/10.1016/j.molmed.2015.02.008
State	Published - May 1 2015

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Ltd.

Keywords

FDA
Federal regulations
Marketing
Stem cell clinics
United States

Publisher link

10.1016/j.molmed.2015.02.008

Find It

Find It at U of M Libraries

Cite this

@article{ac0188e1b60040faa8a2721e8bd6c327,

title = "US stem cell clinics, patient safety, and the FDA",

abstract = "Scholarship on patients accessing unproven stem cell interventions is dominated by research addressing 'stem cell tourism' to such countries as China, India, Mexico, and the Ukraine. However, clinics marketing 'adipose-derived mesenchymal stem cell treatments' are proliferating across the USA. These businesses typically claim to operate in compliance with federal regulations, but careful review of their commercial practices suggests that such clinics are marketing unapproved and noncompliant biological drugs.",

keywords = "FDA, Federal regulations, Marketing, Stem cell clinics, United States",

author = "Leigh Turner",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Ltd.",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.molmed.2015.02.008",

language = "English (US)",

volume = "21",

pages = "271--273",

journal = "Trends in Molecular Medicine",

issn = "1471-4914",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - US stem cell clinics, patient safety, and the FDA

AU - Turner, Leigh

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Scholarship on patients accessing unproven stem cell interventions is dominated by research addressing 'stem cell tourism' to such countries as China, India, Mexico, and the Ukraine. However, clinics marketing 'adipose-derived mesenchymal stem cell treatments' are proliferating across the USA. These businesses typically claim to operate in compliance with federal regulations, but careful review of their commercial practices suggests that such clinics are marketing unapproved and noncompliant biological drugs.

AB - Scholarship on patients accessing unproven stem cell interventions is dominated by research addressing 'stem cell tourism' to such countries as China, India, Mexico, and the Ukraine. However, clinics marketing 'adipose-derived mesenchymal stem cell treatments' are proliferating across the USA. These businesses typically claim to operate in compliance with federal regulations, but careful review of their commercial practices suggests that such clinics are marketing unapproved and noncompliant biological drugs.

KW - FDA

KW - Federal regulations

KW - Marketing

KW - Stem cell clinics

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=84928995897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928995897&partnerID=8YFLogxK

U2 - 10.1016/j.molmed.2015.02.008

DO - 10.1016/j.molmed.2015.02.008

M3 - Comment/debate

C2 - 25945404

AN - SCOPUS:84928995897

SN - 1471-4914

VL - 21

SP - 271

EP - 273

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

IS - 5

ER -

US stem cell clinics, patient safety, and the FDA

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this